Axicabtagene Ciloleucel in Patients with Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1

被引：1

作者：

Locke, Frederick L. ^{[1
]}

Ghobadi, Armin ^{[2
]}

Lekakis, Lazaros J. ^{[3
]}

Miklos, David B. ^{[4
]}

Jacobson, Caron A. ^{[5
]}

Jacobsen, Eric ^{[5
]}

Braunschweig, Ira ^{[6
]}

Oluwole, Olalekan O. ^{[7
]}

Siddiqi, Tanya ^{[8
]}

Lin, Yi ^{[9
]}

Reagan, Patrick M. ^{[10
]}

Farooq, Umar ^{[11
]}

Deol, Abhinav ^{[12
]}

Bot, Adrian ^{[13
]}

Rossi, John M. ^{[13
]}

Jiang, Yizhou ^{[13
]}

Xue, Allen ^{[13
]}

Go, William Y. ^{[13
]}

Neelapu, Sattva S. ^{[14
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Washington Univ, Sch Med, St Louis, MO USA

[3] Univ Miami Hlth Syst, Sylvester Comprehens Care Ctr, Miami, FL USA

[4] Stanford Univ, Stanford, CA 94305 USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA

[7] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[8] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[9] Mayo Clin, Rochester, MN USA

[10] Univ Rochester, Sch Med, Rochester, NY USA

[11] Univ Iowa, Iowa City, IA USA

[12] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA

[13] Kite, Santa Monica, CA USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷

关键词：

CAR T cell therapy; large B cell lymphoma;

D O I：

10.1016/j.clml.2018.07.203

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NHL-102

引用

页码：S276 / S276

页数：1

共 50 条

[41] Primary results from ZUMA-1: a pivotal trial of axicabtagene ciloleucel (axicel; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (NHL)
Locke, Frederick L.
Neelapu, Sattva S.
Bartlett, Nancy L.
Lekakis, Lazaros J.
Miklos, David
Jacobson, Caron A.
Braunschweig, Ira
Oluwole, Olalekan
Siddiqi, Tanya
Lin, Yi
Timmerman, John
Friedberg, Jonathan W.
Bot, Adrian
Rossi, John
Navale, Lynn
Jiang, Yizhou
Aycock, Jeff
Elias, Meg
Wiezorek, Jeff
Go, William Y.
CANCER RESEARCH, 2017, 77
[42] CLINICAL AND BIOLOGIC COVARIATES OF OUTCOMES IN ZUMA-1: A PIVOTAL TRIAL OF AXICABTAGENE CILOLEUCEL (AXI-CEL; KTE-C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON-HODGKIN LYMPHOMA (NHL)
Locke, F. L.
Neelapu, S. S.
Bartlett, N. L.
Lekakis, L. J.
Miklos, D.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O.
Siddiqi, T.
Lin, Y.
Timmerman, J.
Reagan, P. M.
Bot, A.
Rossi, J.
Navale, L.
Jiang, Y.
Aycock, J.
Elias, M.
Wiezorek, J.
Go, W. Y.
HAEMATOLOGICA, 2017, 102 : 172 - 172
[43] A Comparison of One Year Outcomes in ZUMA-1 (axicabtagene ciloleucel) and SCHOLAR-1 in Patients with Refractory, Aggressive Non-Hodgkinlymphoma (NHL)
Neelapu, Sattva S.
Locke, Frederick L.
Bartlett, Nancy L.
Lekakis, Lazaros J.
Reagan, Patrick M.
Miklos, David B.
Jacobson, Caron A.
Braunschweig, Ira
Oluwole, Olalekan O.
Siddiqi, Tanya
Lin, Yi
Crump, Michael
Kuruvilla, John
Van den Neste, Eric W.
Farooq, Umar
Navale, Lynn
Go, William Y.
Wiezorek, Jeffrey S.
Gisselbrecht, Christian
BLOOD, 2017, 130
[44] Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
Ionescu, Filip
Shah, Bijal D.
Menges, Meghan
Reid, Kayla
Bailey, Hanna
DiMaggio, Elizabeth
Gonzalez, Rebecca
Bachmeier, Christina A.
Corallo, Salvatore
Delgado, Luis Cuadrado
Mohammed, Turab
Nishihori, Taiga
Khimani, Farhad
Lazaryan, Aleksandr
Liu, Hien
Davila, Marco
Perna, Fabiana
Chavez, Julio C.
Locke, Frederick L.
Jain, Michael D.
BLOOD, 2023, 142
[45] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S.
Locke, F. L.
Bartlett, N. L.
Lekakis, L. J.
Miklos, D. B.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O. O.
Siddiqi, T.
Lin, Y.
Timmerman, J. M.
Stiff, P. J.
Friedberg, J. W.
Flinn, I. W.
Goy, A.
Hill, B. T.
Smith, M. R.
Deol, A.
Farooq, U.
McSweeney, P.
Munoz, J.
Avivi, I.
Castro, J. E.
Westin, J. R.
Chavez, J. C.
Ghobadi, A.
Komanduri, K. V.
Levy, R.
Jacobsen, E. D.
Witzig, T. E.
Reagan, P.
Bot, A.
Rossi, J.
Navale, L.
Jiang, Y.
Aycock, J.
Elias, M.
Chang, D.
Wiezorek, J.
Go, W. Y.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2531 - 2544
[46] Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Pinnix, Chelsea C.
Gunther, Jillian R.
Dabaja, Bouthaina S.
Adkins, Sherry
Hawkins, Misha
Westin, Jason R.
Fayad, Luis
Ahmed, Sairah
Fowler, Nathan H.
Hagemeister, Fredrick B.
Iyer, Swaminathan P.
Rodriguez, Maria Alma
Lee, Hun Ju
Steiner, Raphael E.
Nair, Ranjit
Strati, Paolo
Parmar, Simrit
Samaniego, Felipe
Wang, Michael
Neelapu, Sattva S.
Nastoupil, Loretta J.
BLOOD, 2019, 134
[47] Earlier steroid use with axicabtagene ciloleucel in patients with relapsed/refractory large B cell lymphoma
Topp, M.
van Meerten, T.
Houot, R.
Minnema, M.
Milpied, N.
Lugtenburg, P.
Thieblemont, C.
Wermke, M.
Song, K.
Aviv, I.
Kuruvilla, J.
Duehrsen, U.
Chu, R.
Zheng, L.
Plaks, V.
Kerber, A.
Kersten, M. J.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 96 - 97
[48] Efficacy, safety, and covariates of outcomes with axicabtagene ciloleucel (axi-cel; KTE-C19) from ZUMA-1, a pivotal trial in patients with refractory, aggressive non-Hodgkin lymphoma (NHL)
Lin, Y.
Locke, L.
Neelapu, S. S.
Bartlett, N. L.
Lekakis, L. J.
Miklos, D.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O.
Siddiqi, T.
Timmerman, J.
Reagan, P. M.
Bot, A.
Rossi, J.
Navale, L.
Jiang, Y.
Aycock, J. S.
Elias, M.
Wiezorek, J.
Go, W. Y.
HUMAN GENE THERAPY, 2017, 28 (12) : A5 - A5
[49] Interim Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel as First-Line Therapy in Patients With High-Risk Large B-Cell Lymphoma
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 16 - 18
[50] The Phase 3, Randomized Study of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma: ZUMA-7
Schmitz, N.
Oluwole, O. O.
Bishop, M. R.
Gisselbrecht, C.
Gordon, L. I.
Kersten, M. J.
Maloney, D. G.
Caballero, M. D.
Kuruvilla, J.
Song, K. W.
Jacobson, C. A.
Nastoupil, L. J.
Riedell, P.
Jiang, Y.
Rossi, J. M.
Lee, L.
Cheng, P.
Locke, F. L.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 90 - 91

← 1 2 3 4 5 →